Human Growth Hormone: all 210 studies that test it
Page 2 of 3. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies InfusionCompletedNCT02655263Not applicable
- A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar TendinopathyWithdrawnNCT02597660Phase 2
- Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)Status unknownNCT02380235Phase 4
- Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short StatureActive, not recruitingNCT02375620Phase 2
- Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and SequelaeStatus unknownNCT02326610Phase 2
- Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenStatus unknownNCT02314676Phase 4
- Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVFStatus unknownNCT02179255Phase 1/2
- Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.CompletedNCT02077348Not applicable
- Growth Response in Girls With Turner SyndromeCompletedNCT01734486Phase 4
- Long Term Effect of Somatropin in Subjects With Intrauterine Growth RetardationCompletedNCT01734447Phase 4
- Somatostatin Analogue Treatment of Acromegaly: Molecular AspectsCompletedNCT01723748Not applicable
- Adjuvant Growth Therapy in in Vitro FertilizationCompletedNCT01715324Phase 4
- Growth Hormone and Brain Functioning After Traumatic Brain InjuryCompletedNCT01699308Phase 1
- Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone DeficiencyTerminatedNCT01698944Phase 4
- Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth RetardationCompletedNCT01697644Phase 4
- Growth Hormone in Poor Responders to IVF TrialTerminatedNCT01616225Phase 2/3
- Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD ChildrenCompletedNCT01613573Phase 1
- Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT01563926Phase 3
- Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult PatientsCompletedNCT01562834Phase 4
- Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658CompletedNCT01529944Phase 3
- Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan SyndromeCompletedNCT01529840Phase 3
- Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner SyndromeCompletedNCT01518062Phase 4
- Use of Somatropin in Turner SyndromeCompletedNCT01518036Phase 3
- Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult VolunteersWithdrawnNCT01512095Phase 1
- Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic HaemodialysisCompletedNCT01502137Phase 1
- Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyCompletedNCT01502124Phase 3
- Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenCompletedNCT01495468Phase 3
- Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.Status unknownNCT01494779Phase 1
- Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male VolunteersCompletedNCT01440686Phase 1
- Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult VolunteersCompletedNCT01401244Phase 1
- Hormone Treatment in Growth Hormone and Testosterone Deficient PatientsTerminatedNCT01397500Phase 2
- Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency ChildrenCompletedNCT01342146Phase 2
- Efficacy and Safety of Growth Hormone Treatment in Spinal Cord InjuryCompletedNCT01329757Phase 3
- Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder PatientsTerminatedNCT01298960Phase 2
- Short Stature Related DistressCompletedNCT01246219Phase 4
- Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie RestrictionCompletedNCT01209429Not applicable
- A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to AdulthoodCompletedNCT01157793Phase 4
- Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)CompletedNCT01090778Phase 2
- r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence TrialCompletedNCT01034735Phase 1
- Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®CompletedNCT01034202Phase 1
- The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal PersonsStatus unknownNCT00969644Not applicable
- Three Times Weekly (TIW) Growth Hormone Therapy in Children on HemodialysisCompletedNCT00943995Phase 3
- A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of SomatropinCompletedNCT00931476Phase 1
- Growth Hormone and Glucose MetabolismCompletedNCT00929799Phase 4
- A Study of Zomacton in Children With Growth Hormone DeficiencyCompletedNCT00884000Phase 3
- Initiating Transdermal Estradiol Therapy in Turner's SyndromeTerminatedNCT00870220Phase 1
- A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted HeightActive, not recruitingNCT00840944Phase 4
- Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone DeficiencyStatus unknownNCT00837863Phase 2
- Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes MellitusCompletedNCT00781547Phase 3
- Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood TransplantTerminatedNCT00737113Phase 1
- Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.WithdrawnNCT00720616Not applicable
- Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and RehabilitationTerminatedNCT00675714Phase 2/3
- Growth Hormone Administration and the Human Immune SystemCompletedNCT00663611Phase 1
- Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone DeficiencyCompletedNCT00646815Not applicable
- Growth Hormone in Amyotrophic Lateral SclerosisCompletedNCT00635960Phase 2
- Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult PatientsCompletedNCT00570011Phase 3
- Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT00567385Phase 4
- Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational AgeCompletedNCT00557336Phase 3
- Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of SatisfactionCompletedNCT00519844Phase 4
- Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00519558Phase 3
- Low Dose Growth Hormone in Obese PCOS WomenWithdrawnNCT00518635Not applicable
- Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production RatesCompletedNCT00517062Early Phase 1
- Growth Hormone Signaling in Vivo in HumansCompletedNCT00512473Not applicable
- Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone DeficiencyCompletedNCT00490191Phase 4
- Growth Hormone in the Treatment of HIV-Associated WastingCompletedNCT00489528Phase 3
- Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With SomatropinCompletedNCT00488124Phase 2
- Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid ContentCompletedNCT00476879Not applicable
- Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic RicketsStatus unknownNCT00473187Phase 1
- Effects of Growth Hormone on the Nitric Oxide PathwayCompletedNCT00470002Phase 1
- Mechanism of Growth Hormone Effects on Adipose TissueCompletedNCT00453557Phase 4
- MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal ChildrenCompletedNCT00452491Phase 3
- Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic ArthritisCompletedNCT00420251Phase 3
- The Effect of Growth Hormone in Very Young Girls With Turner SyndromeCompletedNCT00406926Phase 3
- Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi SyndromeCompletedNCT00372125Not applicable
- 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone DeficiencyStatus unknownNCT00362063Not applicable
- Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic AdultsCompletedNCT00352287Phase 4
- A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.CompletedNCT00300664Phase 2/3
- An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution SyndromeCompletedNCT00294918Phase 2/3
- Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)CompletedNCT00294164Phase 2/3
- Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected PatientsCompletedNCT00287677Phase 4
- The Use of Nutropin Depot in HIV-infected Adult MalesWithdrawnNCT00286676Phase 2/3
- Treatment of Children With Insufficient Secretion of Growth HormoneStatus unknownNCT00271518Phase 3
- Effect of Growth Hormone in Children With Growth Hormone DeficiencyCompletedNCT00262249Phase 3
- Growth Hormone Treatment Study in Children With Cystic FibrosisWithdrawnNCT00256555Phase 2/3
- Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia FracturesCompletedNCT00254514Phase 2
- An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MGCompletedNCT00250250Phase 3
- Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis PatientsCompletedNCT00244075Phase 2
- Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney DiseaseTerminatedNCT00194961Phase 4
- Effect of Cytokines on Growth of Children With Chronic Kidney FailureSuspendedNCT00194883Phase 4
- Growth Hormone Treatment in Short Children Born Small for Gestational AgeCompletedNCT00191529Phase 3
- Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone DeficiencyCompletedNCT00191360Phase 3
- Somatropin Treatment in Patients With SHOX Deficiency and Turner SyndromeCompletedNCT00190658Phase 3
- Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.CompletedNCT00184769Phase 4
- Efficacy on Height in SGA Children Treated With Growth HormoneCompletedNCT00184756Phase 3
- Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00184743Phase 3
- Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00184730Phase 3
- Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 YearsCompletedNCT00184691Phase 3
- Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone DeficiencyCompletedNCT00184678Phase 3
- Growth Hormone Treatment in Adult Patients With Chronic Kidney DiseaseCompletedNCT00184652Phase 2
- Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational AgeCompletedNCT00174408Phase 3